BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 9249283)

  • 1. Treatment of poison ivy/oak allergic contact dermatitis with an extract of jewelweed.
    Long D; Ballentine NH; Marks JG
    Am J Contact Dermat; 1997 Sep; 8(3):150-3. PubMed ID: 9249283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allergic contact dermatitis caused by Lithraea molleoides and Lithraea brasiliensis: identification and characterization of the responsible allergens.
    Alé SI; Ferreira F; González G; Epstein W
    Am J Contact Dermat; 1997 Sep; 8(3):144-9. PubMed ID: 9249282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of jewelweed, Impatiens capensis, the related cultivar I. balsamina and the component, lawsone in preventing post poison ivy exposure contact dermatitis.
    Abrams Motz V; Bowers CP; Mull Young L; Kinder DH
    J Ethnopharmacol; 2012 Aug; 143(1):314-8. PubMed ID: 22766473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of poison ivy and poison oak allergic contact dermatitis by quaternium-18 bentonite.
    Marks JG; Fowler JF; Sheretz EF; Rietschel RL
    J Am Acad Dermatol; 1995 Aug; 33(2 Pt 1):212-6. PubMed ID: 7622647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of the saponin component of Impatiens capensis Meerb.in preventing urushiol-induced contact dermatitis.
    Motz VA; Bowers CP; Kneubehl AR; Lendrum EC; Young LM; Kinder DH
    J Ethnopharmacol; 2015 Mar; 162():163-7. PubMed ID: 25543019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occupational poison ivy and oak dermatitis.
    Epstein WL
    Dermatol Clin; 1994 Jul; 12(3):511-6. PubMed ID: 7923948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of cross-reactions between mango contact allergens and urushiol.
    Oka K; Saito F; Yasuhara T; Sugimoto A
    Contact Dermatitis; 2004; 51(5-6):292-6. PubMed ID: 15606656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the mango-poison ivy connection: the riddle of discriminative plant dermatitis.
    Hershko K; Weinberg I; Ingber A
    Contact Dermatitis; 2005 Jan; 52(1):3-5. PubMed ID: 15701120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the ability of the topical skin protectant (TSP) to protect against contact dermatitis to urushiol (Rhus) antigen.
    Vidmar DA; Iwane MK
    Am J Contact Dermat; 1999 Dec; 10(4):190-7. PubMed ID: 10594293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyposensitization to poison ivy after working in a cashew nut shell oil processing factory.
    Reginella RF; Fairfield JC; Marks JG
    Contact Dermatitis; 1989 Apr; 20(4):274-9. PubMed ID: 2526711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and treatment of poison ivy dermatitis.
    Briant D; Brouder G
    Nurse Pract; 1983; 8(7):13, 16, 19 passim. PubMed ID: 6225038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of antigen specific hyposensitization to poison oak in sensitized adults.
    Epstein WL; Byers VS; Frankart W
    Arch Dermatol; 1982 Sep; 118(9):630-3. PubMed ID: 6180687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical prevention of poison ivy/oak dermatitis.
    Epstein WL
    Arch Dermatol; 1989 Apr; 125(4):499-501. PubMed ID: 2522756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poison oak hyposensitization. Evaluation of purified urushiol.
    Epstein WL; Baer H; Dawson CR; Khurana RG
    Arch Dermatol; 1974 Mar; 109(3):356-60. PubMed ID: 4273614
    [No Abstract]   [Full Text] [Related]  

  • 15. Topical pimecrolimus in the treatment of human allergic contact dermatitis.
    Amrol D; Keitel D; Hagaman D; Murray J
    Ann Allergy Asthma Immunol; 2003 Dec; 91(6):563-6. PubMed ID: 14700441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preservation of allergic contact dermatitis to poison ivy (urushiol) in late HIV disease. The implications and relevance to immunotherapy with contact allergens.
    Smith KJ; Skelton HG; Nelson A; Wagner KF; Hackley BE
    Dermatology; 1997; 195(2):145-9. PubMed ID: 9310722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urushiol Patch Test Using the T.R.U.E. TEST System.
    Kim Y; Longenecker A; ElSohly MA; Gul W; Hage RJ; Hamann CP; Marks JG
    Dermatitis; 2018; 29(3):127-131. PubMed ID: 29762206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basophil degranulation induced by oral poison ivy antigen.
    Shelley WB; Resnik SS
    Arch Dermatol; 1965 Aug; 92(2):147-50. PubMed ID: 11850914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poison ivy, oak, and sumac dermatitis.
    Lee NP; Arriola ER
    West J Med; 1999; 171(5-6):354-5. PubMed ID: 10639874
    [No Abstract]   [Full Text] [Related]  

  • 20. Patch testing versus history in poison ivy/oak dermatitis.
    Zhai H; Chang YC; Singh M; Maibach HI
    Contact Dermatitis; 1997 Apr; 36(4):226. PubMed ID: 9165209
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.